HOME >> BIOLOGY >> NEWS
Secretary Abraham announces next steps for artificial retina project

LOS ANGELES Today, Secretary of Energy Spencer Abraham toured the University of Southern California's ophthalmology laboratories at the Doheny Eye Institute and heard from the national research team that hopes to restore vision to millions of people with blindness caused by retinal disorders. As a result of recent breakthroughs in science and engineering technology, Abraham announced that DOE will commit $9 million over three years to augment artificial retina research, including support for a laboratory within the Doheny Eye Institute on the USC campus.

The DOE national labs, partnering with the University of Southern California and North Carolina State University, are designing a micro-electronic device that would be implanted in the eye on the surface of the retina. A microelectrode array would perform the function of normal photoreceptive cells.

"Restoring vision to patients with retinal disorders is the truly marvelous goal of this team of researchers," said Secretary Abraham before an audience on the campus of USC. "That the unique resources of government laboratories are helping to meet this goal is another demonstration of their benefit to the Nation. We are always looking for areas in which our interdisciplinary strengths can be leveraged to revolutionize areas of science, engineering and technology, and to improve quality of life for millions of people."

The artificial retina could help those blinded by age-related macular degeneration or retinitis pigmentosa where neural wiring from the eye to brain is intact, but the eyes lack photoreceptor activity. The artificial retina is a device that captures visual signals and sends them to the brain in the form of electrical impulses. The device is a miniature disc that contains an electrode array that can be implanted in the back of the eye to replace a damaged retina. Visual signals are captured by a small video camera in the eyeglasses of the blind person and processed through a
'"/>

Contact: Jeff Sherwood
jeff.sherwood@hq.doe.gov
202-586-5806
DOE/US Department of Energy
25-Nov-2002


Page: 1 2 3

Related biology news :

1. Secretary of Energy announces seven E.O. Lawrence Award Winners
2. Former US Secretary of the Interior Bruce Babbitt to speak at science symposium
3. Francis Collins and Ari Patrinos receive Energy Secretarys Gold Award for Human Genome Project
4. UC Riversides Brian Federici receives Secretarys Annual Honor Award from USDA
5. Interior Secretary Bruce Babbitt To Speak At Ecological Society of Americas 1998 Annual Meeting
6. Secretary Babbitt To Visit Smokies To Learn More Of Scientific Amphibian Project And Declining Frog And Toad Populations
7. Popular Science announces Third Annual Brilliant 10
8. The American Phytopathological Society announces 2004 awards
9. NSF announces six FIBR awards to tackle some of biologys most challenging questions
10. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
11. JGI announces community sequencing program portfolio

Post Your Comments:
(Date:10/22/2014)... Medicine® scientists helps explain how bipolar disorder affects the ... therapies to treat the mental illness. , Scientists ... method recognized with the 2014 Nobel Prize in ... from mice with bipolar-like behaviors. In the synapses (where ... structures with concentrated levels of ANK3 -- the gene ...
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst firm ... half of the world,s population will have a chip-based ... Europe . Asia , ... market accounting for more than 60% of all National ... Acuity,s report  -- "The Global National eID ...
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2
(Date:10/25/2014)... , October 24, 2014 ... Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... Thursday, October 23, 2014, ended on a positive note ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: